ArticleAesthetic plastic surgery2026
Fat Grafting via the Supraorbital Approach for Upper-Eyelid Depression Correction: A Retrospective Study.
Article in Aesthetic plastic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo evaluate the efficacy and safety of combined double-eyelid revision and autologous fat grafting via the supraorbital approach for correcting post-blepharoplasty upper-eyelid depression.
methodsA consecutive retrospective cohort of 32 patients (30 females; mean age 43 years) with post-blepharoplasty upper-eyelid depression underwent combined double-eyelid revision and autologous fat grafting via the supraorbital approach between January 2020 and January 2025. Lipoaspirate obtained from the thigh or abdomen was refined by centrifugation and injected into the retro-orbicularis oculi fat (ROOF) layer through the same supraorbital incision. Efficacy was assessed six months postoperatively using the Global Aesthetic Improvement Scale (GAIS) and a 5-point patient-rated Likert scale.
resultsAll 64 eyelids achieved immediate volume restoration and a natural supratarsal fold, no palpable nodules or eyelid dysfunction occurred. At 6 months, 81.3% (26/32) were judged "very much improved" and 12.5% (4/32) "much improved" on GAIS; 87.5% (28/32) self-rated the outcome as "excellent." Mild recurrent hollowing occurred in 4 patients (12.5%), of whom 3 underwent secondary grafting.
conclusionThe supraorbital route enables accurate placement and even distribution of fat with minimal trauma during revision double-eyelid surgery. Upper-eyelid depression was effectively corrected and aesthetic outcomes significantly improved, confirming the feasibility and safety of this technique in a single-center retrospective cohort. LEVEL OF EVIDENCE V: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Indexed as
Identifiers
42303763What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.